Abstract LB406: Active RAS inhibition intercepts pancreas cancer in mice
Minh T. Than, Lucie Dequiedt, Rina Sor, Shreya Nair et autres
Abstract Cancer interception is a clinical approach to eliminate pre-malignant lesions, distinct from approaches to treat invasive cancer, but effective strategies in pancreatic ductal adenocarcinoma (PDAC) remain to be identified. Conceptually, interception strategies should target precancerous lesions such as pancreatic intraepithelial neoplasia …
us (code pays fourni par la source)